This product is not intended for human or animal use, injection, consumption, diagnostic use, therapeutic use, clinical use, or compounding
IGF-1 LR3 Clinical Evidence Context Direct human evidence on IGF-1 LR3 There are no published human clinical trials of IGF-1 LR3 itself
This is why we're so relentless about quality at Real Peptides
Systemic Inflammation and Post-Injury Recovery For patients with widespread musculoskeletal inflammation, chronic soft tissue pain, or a recent surgical recovery, BPC-157 is most often prescribed as part of the Wolverine Stack, which combines BPC-157 with TB-500 (Thymosin Beta-4) for synergistic tissue repair
Helps maintain the consistency and integrity of peptides after reconstitution, supporting more reliable outcomes when storing and using prepared solutions over time